Physician profile
Douglas Allen
NPI 1700975240
$1,056.19
in general payments reported to CMS, 2019-2025
17 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $186 · 2021: $39.44 · 2022: $75.97 · 2023: $226 · 2024: $42.24 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $201.63 | 2022-2025 | Xtampza |
| Boston Scientific Corporation | $155.56 | 2023 | |
| Medtronic USA, INC. | $128.86 | 2020 | |
| Abbvie INC. | $91.14 | 2019-2023 | Synthroid |
| Forte Bio-Pharma LLC | $88.94 | 2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.53 | 2019-2020 | |
| Braeburn INC. | $60.53 | 2025 | Brixadi |
| Ibsa Pharma INC. | $58.83 | 2019-2020 | |
| Janssen Biotech, INC. | $32.80 | 2019 | |
| Novo Nordisk INC | $31.34 | 2019 | |
| Zyla Life Sciences, INC. | $23.64 | 2019 | |
| Mdd US Operations, LLC | $20.98 | 2021 | |
| Merck Sharp & Dohme LLC | $18.75 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.46 | 2021 | |
| Endo Pharmaceuticals INC. | $18.06 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.57 | 2025 | Zepbound |
| Allergan, INC. | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.